TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31674641

Group type: EXPERIMENTAL
Intervention: High-Dose Teriparatide (40-μg daily) + Denosumab (60 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-Dose Teriparatide (20-μg daily) + Denosumab (60 mg)
Number of subjects: 60
Study: 29524027

Group type: EXPERIMENTAL
Intervention: Clinpro XT Varnish (CXT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fuji IX GP FAST (FJ)
Number of subjects: 56
Study: 27003948

Group type: EXPERIMENTAL
Intervention: 30 min of a computer‐based Stroop task (mental fatigue)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30‐min emotionally neutral documentary (control)
Number of subjects: 20
Study: 24495364

Group type: EXPERIMENTAL
Intervention: Regular exercise (15-30 minutes, three times per week for the past 6 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Not exercising regularly for the past 12 months (control group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Regular exercise (active group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Not exercising regularly (control group)
Number of subjects: 160
Study: 21316972

Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Single-bundle ACL reconstruction
Number of subjects: 66

Group type: COMPARATOR
Intervention: Healthy control individuals
Number of subjects: 66
Study: 20858609

Group type: EXPERIMENTAL
Intervention: Carotid Angioplasty and Stenting (CAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical Therapy Alone
Number of subjects: 0
Study: 19022005

Group type: COMPARATOR
Intervention: Conventional osteosynthesis (transsternal or peristernal wiring; n = 440)
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Osteosynthesis with additional lateral reinforcement (Robicsek; n = 375)
Number of subjects: 815
Study: 16569929

Group type: EXPERIMENTAL
Intervention: NaHCO3 4.2% injected as a bolus (rapid infusion)
Number of subjects: 29

Group type: COMPARATOR
Intervention: NaHCO3 4.2% administered over a 30-min period (slow infusion)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups (rapid and slow infusion)
Number of subjects: 29
Study: 14524580

Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis (HD group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 17
Study: 10739167

Group type: EXPERIMENTAL
Intervention: CYP2D6 ultrarapid metabolizers
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: CYP2D6 poor metabolizer genotype
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: CYP2D6 activity
Number of subjects: 976
Study: 8638750

Group type: COMPARATOR
Intervention: Placebo arthroscopy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Arthroscopic lavage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Standard arthroscopic debridement
Number of subjects: 10
Study: 1450091

Group type: EXPERIMENTAL
Intervention: Nicorandil (10-40 mg/day, b.i.d.)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Diltiazem (60-240 mg/day, b.i.d.)
Number of subjects: 37
Study: 6420817

Group type: EXPERIMENTAL
Intervention: Ethanol (various doses)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ethanol (one dose level)
Number of subjects: 5
Study: 30601431

Group type: EXPERIMENTAL
Intervention: 1 hour of music
Number of subjects: 50

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 50
Study: 29575770

Group type: EXPERIMENTAL
Intervention: Moroctocog alfa (albumin-free presentation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moroctocog alfa (previous technique)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study: 26896742

Group type: EXPERIMENTAL
Intervention: Escitalopram (single dose)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (single dose)
Number of subjects: 36
Study: 24892763

Group type: EXPERIMENTAL
Intervention: PHiD-CV
Number of subjects: 24000

Group type: COMPARATOR
Intervention: Control (hepatitis vaccine)
Number of subjects: 24000
Study: 22846389

Group type: EXPERIMENTAL
Intervention: Self-administered cognitive behavior therapy (CBT)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Standard cognitive behavior therapy (CBT)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 171
Study: 20303080

Group type: EXPERIMENTAL
Intervention: Nurse-delivered care
Number of subjects: 701

Group type: COMPARATOR
Intervention: Standard care by general practitioners
Number of subjects: 701
Study: 18549331

Group type: EXPERIMENTAL
Intervention: AMG-531 (Romiplostim)
Number of subjects: 0
Study: 15772927

Group type: EXPERIMENTAL
Intervention: Normal hemoglobin level (135-160 g/L) achieved with epoetin alfa (n=10)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Subnormal hemoglobin level (90-120 g/L) (n=14)
Number of subjects: 33
Study: 11888871

Group type: EXPERIMENTAL
Intervention: Postoperative irinotecan/FUDR
Number of subjects: 185

Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 185
Study: 10403869

Group type: EXPERIMENTAL
Intervention: Pressure-limited cuff
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-volume low-pressure cuff
Number of subjects: 15
Study: 8775035

Group type: EXPERIMENTAL
Intervention: Topical lidocaine anaesthesia
Number of subjects: 62

Group type: COMPARATOR
Intervention: Caudal anaesthesia
Number of subjects: 62
Study: 2210620

Group type: EXPERIMENTAL
Intervention: Ciclosporin
Number of subjects: 0
Study: 6992978

Group type: EXPERIMENTAL
Intervention: Cytoxan + CCNU + methotrexate
Number of subjects: 210

Group type: COMPARATOR
Intervention: Adriamycin and procarbazine
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 210
Study: 31685304

Group type: COMPARATOR
Intervention: Inspiratory pressure of 10 cm H2O
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure of 15 cm H2O
Number of subjects: 40
Study: 31824233

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bilateral Arm Training (BAT)
Number of subjects: 23
Study: 28934782

Group type: EXPERIMENTAL
Intervention: Full-dose ketoprofen (0.5 mg/kg every 6 hours for 48 hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose ketoprofen (half doses and quarter doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26424510

Group type: EXPERIMENTAL
Intervention: Closed reduction and K-wire pinning
Number of subjects: 742

Group type: COMPARATOR
Intervention: Conservative treatment with a cast
Number of subjects: 742
Study: 22873657

Group type: EXPERIMENTAL
Intervention: EMD + NBM
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: EMD + β‐TCP
Number of subjects: 22
Study: 20528206

Group type: EXPERIMENTAL
Intervention: PCOS women
Number of subjects: 30
Study: 19805918

Group type: EXPERIMENTAL
Intervention: Better lung (lower LIS) down position
Number of subjects: 16

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 16

Group type: COMPARATOR
Intervention: Better lung-up position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Positioning-related arterial oxygenation
Number of subjects: 16
Study: 17761231

Group type: EXPERIMENTAL
Intervention: Established intervention
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Established intervention plus DASH dietary pattern
Number of subjects: 810

Group type: COMPARATOR
Intervention: Advice-only control group
Number of subjects: 810
Study: 15801959

Group type: EXPERIMENTAL
Intervention: Cryosupernatant plasma (CSP)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Fresh frozen plasma (FFP)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Cryosupernatant plasma (CSP) and Fresh frozen plasma (FFP)
Number of subjects: 236
Study: 12165991

Group type: EXPERIMENTAL
Intervention: F2000
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dyract AP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Compoglass F
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Elan
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 100
Study: 9863784

Group type: EXPERIMENTAL
Intervention: 10 mg inhaled zanamivir, twice daily for 5 days
Number of subjects: 455

Group type: COMPARATOR
Intervention: Placebo, twice daily for 5 days
Number of subjects: 455
Study: 8847377

Group type: EXPERIMENTAL
Intervention: 12-week community-based large group parent training (Community/Group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12-week clinic-based individual parent training (Clinic/Individual)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 0
Study: 2195153

Group type: EXPERIMENTAL
Intervention: Dentifrice containing 0.075% sanguinaria extract and 2% zinc chloride, followed by a mouthrinse containing 0.03% sanguinaria extract and 0.2% zinc chloride.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 60
Study: 581636

Group type: EXPERIMENTAL
Intervention: Nonpasteurized yogurt
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pasteurized yogurt
Number of subjects: 54

Group type: COMPARATOR
Intervention: 2% butterfat milk
Number of subjects: 54

Group type: COMPARATOR
Intervention: Dietary intake
Number of subjects: 54
Study: 31851321

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: HER2-HER3 dimerization
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: HER dimer imaging and conventional mutation analyses
Number of subjects: 550
Study: 31444050

Group type: EXPERIMENTAL
Intervention: High free androgen index (FAI ≥5%)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: High free androgen index (FAI ≥5%) among women with high BMI
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: High free androgen index (FAI ≥5%) among women with normal BMI
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Polycystic ovary morphology
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Polycystic ovary morphology among women with normal BMI
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Polycystic ovary morphology among women with high BMI
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: LH, sex hormone‐binding globulin (SHBG), and anti‐Müllerian hormone (AMH)
Number of subjects: 947
Study: 28713084

Group type: EXPERIMENTAL
Intervention: Manual therapy + Acupuncture + Vestibular rehabilitation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Manual therapy + Acupuncture
Number of subjects: 109

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 109
Study: 25380275

Group type: EXPERIMENTAL
Intervention: Oral estradiol
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 643
Study: 23604551

Group type: EXPERIMENTAL
Intervention: Oral strategy with sitagliptin 100 mg/day
Number of subjects: 653

Group type: COMPARATOR
Intervention: Injectable strategy with liraglutide starting at 0.6 mg/day, up-titrated to 1.2 mg/day after 1 week
Number of subjects: 653
Study: 21767371

Group type: EXPERIMENTAL
Intervention: Heparin-bonded endoluminal bypass
Number of subjects: 222

Group type: COMPARATOR
Intervention: Surgical femoro-popliteal bypass
Number of subjects: 222
Study: 19836774

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneous every 6 months for 36 months
Number of subjects: 1468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1468
Study: 17097943

Group type: COMPARATOR
Intervention: Calcineurin inhibitors (CNIs)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Rapamycin
Number of subjects: 64
Study: 15236812

Group type: EXPERIMENTAL
Intervention: Disulfiram treatment
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control (no disulfiram treatment)
Number of subjects: 191
Study: 10925508

Group type: EXPERIMENTAL
Intervention: Colgate (Baking Soda and Peroxide)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Macleans (Whitening)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Colgate (Sensation Whitening)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Water
Number of subjects: 64
Study: 9351879

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Prednisone (in both Groups 2 and 3)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Alendronate (in Group 3)
Number of subjects: 43
Study: 1852394

Group type: EXPERIMENTAL
Intervention: Biofeedback training for control of accommodation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no biofeedback training)
Number of subjects: 30
Study: 6843193

Group type: EXPERIMENTAL
Intervention: Organized volunteer‐based emergency first‐responder system
Number of subjects: 36

Group type: COMPARATOR
Intervention: Household telephone survey conducted immediately before project initiation, 3 months and 13 months after implementation
Number of subjects: 36
Study: 30925120

Group type: EXPERIMENTAL
Intervention: WhatsApp intervention (4 persuasive messages sent via Bulk System)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group (no WhatsApp messages)
Number of subjects: 548
Study: 30976031

Group type: EXPERIMENTAL
Intervention: Ensemble of diverse thermostatically controlled loads with varying disorder probability distributions (DPDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control of the aggregator commanding devices to lower the rate r
Number of subjects: 0
Study: 28129779

Group type: EXPERIMENTAL
Intervention: Intervention group (exercise, health education, socialization and group auditory rehabilitation (GAR)) attending YMCA twice a week for 10 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (GAR only) attending 60-min GAR sessions once a week for 10 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional fitness measures (gait speed, 30-s Sit to Stand Test)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loneliness, depression, social participation and social support measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feasibility measures (recruitment, randomization, retention, acceptability)
Number of subjects: 0
Study: 26936426

Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 505
Study: 25263744

Group type: EXPERIMENTAL
Intervention: Growth hormone (Genotropin(®) 0.033 mg/kg/day) for 2 years
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no treatment in the first year, double dose in the second year)
Number of subjects: 19
Study: 22375973

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 20921838

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SNB distal to bifurcation (group D)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ultrasound-guided SNB proximal to bifurcation (group P)
Number of subjects: 50
Study: 18540252

Group type: EXPERIMENTAL
Intervention: L-T4 therapy with appropriate doses, improvement of clinical findings, normalization of serum total T4 levels, and persistently high TSH concentrations.
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group with adequate suppression of TSH (<6 mU/l) with therapy.
Number of subjects: 500
Study: 15723890

Group type: EXPERIMENTAL
Intervention: Expressive writing
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 12204500

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 17
Study: 10101319

Group type: COMPARATOR
Intervention: Conventional surgical technique (slide hammer and femoral rasps)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mechanical high frequency vibration rasp
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Modified surgical technique
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Modified surgical technique with high frequency vibration rasp
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Conventional surgical technique with distal venting hole
Number of subjects: 36
Study: 8992429

Group type: EXPERIMENTAL
Intervention: 0.1 mg octreotide acetate
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Isotonic sodium-chloride (control)
Number of subjects: 1199
Study: 2109498

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 112
Study: 599107

Group type: EXPERIMENTAL
Intervention: Contingent feedback with monetary rewards for appropriate pressure changes
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Noncontingent beat‐to‐beat feedback with rewards equal to the mean of the contingent group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Noncontingent feedback presented randomly with respect to heart beats with rewards equal to the mean of the contingent group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Instructions alone with a bonus paid at the conclusion of the experiment
Number of subjects: 40
Study: 30318128

Group type: EXPERIMENTAL
Intervention: Wax bath treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard care with daily home exercises
Number of subjects: 36
Study: 28104206

Group type: EXPERIMENTAL
Intervention: Hybrid sirolimus-eluting stent (SES) with biodegradable polymer
Number of subjects: 330

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES) with durable polymer
Number of subjects: 330
Study: 25447331

Group type: EXPERIMENTAL
Intervention: Disgust induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative emotion induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive emotion induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral control induction
Number of subjects: 0
Study: 23149178

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous omeprazole
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1 mg/kg intravenous omeprazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both doses of omeprazole
Number of subjects: 40
Study: 21718094

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy started at diagnosis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard multiple daily insulin injections (MDIs)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Number of subjects: 24
Study: 19786862

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1‐0.7 microg x kg(‐1) x h(‐1))
Number of subjects: 306

Group type: COMPARATOR
Intervention: Morphine (10‐70 microg x kg(‐1) x h(‐1))
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 306
Study: 23108477

Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND) school meals for 3 months
Number of subjects: 834

Group type: COMPARATOR
Intervention: Usual packed lunch (control) for 3 months
Number of subjects: 834
Study: 15818288

Group type: EXPERIMENTAL
Intervention: Gatifloxacin 10 mg/kg once daily for 10 days
Number of subjects: 354

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 90 mg/6.4 mg in 2 divided doses for 10 days
Number of subjects: 354
Study: 12861138

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol tablet placed in the inner one third of the vagina
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol tablet placed in the outer one third of the vagina
Number of subjects: 10
Study: 9824602

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg twice daily for five days
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily for five days
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control period with no treatment
Number of subjects: 13
Study: 8563504

Group type: EXPERIMENTAL
Intervention: Wheezing in chronic bronchitis patients
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Wheezing in asthma patients
Number of subjects: 160
Study: 2496740

Group type: EXPERIMENTAL
Intervention: 150 mg recombinant tissue plasminogen activator (rt-PA) over five hours
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 871356

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 69

Group type: COMPARATOR
Intervention: Papaveretum
Number of subjects: 69
Study: 12088158

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: COMPARATOR
Intervention: Healthy Control
Number of subjects: 85
Study: 28929862

Group type: EXPERIMENTAL
Intervention: Computed tomography analyzed by experienced consultant radiologists
Number of subjects: 1065

Group type: COMPARATOR
Intervention: Computed tomography analyzed by inexperienced resident radiologists
Number of subjects: 1065
Study: 27212669

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 139
Study: 24858309

Group type: EXPERIMENTAL
Intervention: Feature-present arrays (R among Ps)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feature-absent arrays (P among Rs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homogeneous arrays (either all Rs or all Ps)
Number of subjects: 0
Study: 22200516

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 20362978

Group type: EXPERIMENTAL
Intervention: Cognitive therapy techniques adherence (cognitive methods and negotiating content/structuring sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patient facilitation or inhibition of therapist adherence
Number of subjects: 60

Group type: COMPARATOR
Intervention: Behavioral methods/homework adherence
Number of subjects: 60

Group type: COMPARATOR
Intervention: Therapeutic alliance
Number of subjects: 60
Study: 18448749

Group type: EXPERIMENTAL
Intervention: Trendelenburg position (30 degrees) and a pulmonary recruitment maneuver consisting of five manual inflations of the lung
Number of subjects: 116

Group type: COMPARATOR
Intervention: Passive deflation of the abdominal cavity through the cannula (Control group)
Number of subjects: 116
Study: 15449050

Group type: EXPERIMENTAL
Intervention: ECG-gated 18F-FDG/(99m)Tc-sestamibi DISA SPECT
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: (99m)Tc-sestamibi
Number of subjects: 33

Group type: COMPARATOR
Intervention: 18F-FDG/13N-ammonia PET
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cine-MRI
Number of subjects: 33